Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Free Report) – Zacks Research issued their FY2026 earnings per share (EPS) estimates for shares of Baird Medical Investment in a research report issued to clients and investors on Wednesday, August 19th. Zacks Research analyst T. Kerr anticipates that the company will post earnings of $0.10 per share for the year. Zacks Research also issued estimates for Baird Medical Investment’s FY2027 earnings at $0.14 EPS.
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Baird Medical Investment in a research note on Wednesday, August 5th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.
Baird Medical Investment Trading Down 2.5%
BDMD opened at $1.16 on Friday. The company has a 50 day moving average of $1.11 and a two-hundred day moving average of $1.53. Baird Medical Investment has a 52-week low of $0.76 and a 52-week high of $3.70.
Institutional Trading of Baird Medical Investment
Several hedge funds and other institutional investors have recently bought and sold shares of BDMD. Geode Capital Management LLC lifted its position in shares of Baird Medical Investment by 59.7% in the 2nd quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock worth $93,000 after buying an additional 9,511 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Baird Medical Investment during the 2nd quarter valued at about $142,000. Finally, Citadel Advisors LLC acquired a new stake in Baird Medical Investment during the third quarter worth about $99,000. 19.78% of the stock is owned by institutional investors.
Baird Medical Investment Company Profile
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Read More
- Five stocks we like better than Baird Medical Investment
- Coherent Stock Is Cooling Off Just as Its AI Thermal Opportunity Heats Up
- Moderna’s 177% Surge Has Investors Asking What Comes Next
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
